These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 8658903

  • 1. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
    Izutani H, Miyagawa S, Shirakura R, Mikata S, Tanemura M, Fukushima N, Nakata S, Matsuda H.
    Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
    [No Abstract] [Full Text] [Related]

  • 2. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
    Izutani H, Miyagawa S, Matsumiya G, Nakata S, Shimazaki Y, Matsuda H, Shirakura R.
    Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H, Hamano K, Suzuki K, Shirasawa B, Gohra H, Katoh T, Fujimura Y, Tsuboi H, Esato K.
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A, Krzymański M, Deja A, Pawliczak E, Idasiak-Piechocka I.
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract] [Full Text] [Related]

  • 8. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J, Médot M, Battafarano R, Benedetti E, Kim S, Dunn DL.
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
    Sablinski T, Sayegh MH, Kut JP, Tilney NL, Milford EL, Kupiec-Weglinski JW.
    Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.